MEREO BIOPHARMA GROUP PLC

Ticker: MREO CUSIP: 589492107 Class: ADR

ALKEON CAPITAL MANAGEMENT LLC's Holding History (CIK: 0001230239)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 3,698,100 Value ($000) $7,618 Avg Close Range
Q2 2025
Shares 4,698,100 Value ($000) $12,732 Avg Close Range
Q1 2025
Shares 4,698,100 Value ($000) $10,571 Avg Close Range
Q4 2024
Shares 4,698,100 Value ($000) $16,443 Avg Close Range
Q3 2024
Shares 4,698,100 Value ($000) $19,309 Avg Close Range
Q2 2024
Shares 4,698,100 Value ($000) $16,913 Avg Close Range
Q1 2024
Shares 4,238,100 Value ($000) $13,986 Avg Close Range
Q4 2023
Shares 4,238,100 Value ($000) $9,790 Avg Close Range
Q3 2023
Shares 3,738,100 Value ($000) $4,822 Avg Close Range
Q2 2023
Shares 3,738,100 Value ($000) $4,934 Avg Close Range
Q1 2023
Shares 2,385,600 Value ($000) $1,686 Avg Close Range
Q4 2022
Shares 2,135,600 Value ($000) $1,602 Avg Close Range
Q3 2022
Shares 2,135,600 Value ($000) $1,839 Avg Close Range
Q2 2022
Shares 1,735,600 Value ($000) $1,944 Avg Close Range
Q1 2022
Shares 1,935,600 Value ($000) $2,168 Avg Close Range
Q4 2021
Shares 1,935,600 Value ($000) $3,097 Avg Close Range
Q3 2021
Shares 1,935,600 Value ($000) $4,684 Avg Close Range
Q2 2021
Shares 1,935,600 Value ($000) $6,136 Avg Close Range
Q1 2021
Shares 1,935,600 Value ($000) $6,523 Avg Close Range
Q4 2020
Shares 1,935,600 Value ($000) $6,929 Avg Close Range